临终关怀机构特征与苯二氮䓬类及抗精神病药处方相关
该横断面分析纳入2017年1393622名≥65岁临终关怀Medicare受益人(4219家机构),发现机构层面苯二氮䓬类和抗精神病药处方率差异极大。最高处方五分位机构中少数族裔患者比例较小,农村受益人更多见于最高苯二氮䓬类处方五分位,大型机构和营利性机构在两类药物最高处方五分位中均过度代表。
要点
- 临终关怀机构苯二氮䓬类处方率从最低五分位中位数11.9%到最高五分位80.0%,差异悬殊。
- 抗精神病药处方率从最低五分位中位数5.5%到最高五分位63.9%,差异同样显著。
- 最高处方五分位机构中非西班牙裔黑人和西班牙裔患者比例较低,大型及营利性机构过度代表。
核心结论
- 临终关怀机构中苯二氮䓬类和抗精神病药处方率在患者临床特征之外的因素上存在显著差异。
研究设计与样本
- 横断面分析,纳入2017年临终关怀登记的≥65岁Medicare受益人1393622名,分布于4219家临终关怀机构。
主要发现
- 苯二氮䓬类处方率最低五分位中位数11.9%(IQR 5.9,22.2),最高五分位80.0%(IQR 76.9,84.2)。
- 抗精神病药处方率最低五分位5.5%(IQR 2.9,7.7),最高五分位63.9%(IQR 56.1,72.0)。
- 最高苯二氮䓬类处方五分位中,非西班牙裔黑人RR 0.7(95%CI 0.6-0.7),西班牙裔RR 0.4(95%CI 0.3-0.5)。
- 最高抗精神病药处方五分位中,非西班牙裔黑人RR 0.7(95%CI 0.6-0.8),西班牙裔RR 0.4(95%CI 0.3-0.5)。
- 最高苯二氮䓬类处方五分位中农村受益人RR 1.3(95%CI 1.2-1.4),抗精神病药无此关系。
关键数值与推荐
- 大型临终关怀机构在最高苯二氮䓬类处方五分位RR 2.6(95%CI 2.5-2.7),最高抗精神病药处方五分位RR 2.7(95%CI 2.6-2.8)。
- 营利性机构在最高苯二氮䓬类处方五分位RR 2.4(95%CI 2.3-2.4),最高抗精神病药处方五分位RR 2.3(95%CI 2.2-2.4)。
- 处方率在不同人口普查区域间存在广泛差异。
临床怎么用
- 老年医学科医生在临终关怀协作中可关注机构层面苯二氮䓬类和抗精神病药处方模式差异。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Benzodiazepine and antipsychotic medications are routinely prescribed for symptom management in hospice patients, but have significant risks for older adults. We explored the extent to which patient and hospice agency characteristics are associated with variations in their prescribing. METHODS: Cross-sectional analysis of hospice-enrolled Medicare beneficiaries aged ≥65 years in 2017 (N = 1,393,622 in 4219 hospice agencies). The main outcome was the hospice agency-level rate of enrollees with benzodiazepine and antipsychotic prescription fills divided into quintiles. Rate ratios were used to compare the agencies with the highest and lowest prescription across patient and agency characteristics. RESULTS: In 2017, hospice agency prescribing rates varied widely: for benzodiazepines, from a median of 11.9% (IQR 5.9,22.2) in the lowest-prescribing quintile to 80.0% (IQR 76.9,84.2) in the highest-prescribing quintile; for antipsychotics, it ranged from 5.5% (IQR 2.9,7.7) in the lowest to 63.9% (IQR 56.1,72.0) in the highest. Among the highest benzodiazepine- and antipsychotic- prescribing hospice agencies, there was a smaller proportion of patients from minoritized populations (benzodiazepine: non-Hispanic Black rate ratio [RR] [Q5/Q1] 0.7, 95% CI 0.6-0.7, Hispanic RR 0.4, 95% CI 0.3-0.5; antipsychotic: non-Hispanic Black RR 0.7, 95% CI 0.6-0.8, Hispanic RR 0.4, 95% CI 0.3-0.5). A greater proportion of rural beneficiaries were in the highest benzodiazepine-prescribing quintile (RR 1.3, 95% CI 1.2-1.4), whereas this relationship was not present for antipsychotics. Larger hospice agencies were over-represented in the highest prescribing quintile for both benzodiazepines (RR 2.6, 95% CI 2.5-2.7) and antipsychotics (RR 2.7, 95% CI 2.6-2.8), as were for-profit agencies (benzodiazepine: RR 2.4, 95% CI 2.3-2.4; antipsychotic: RR 2.3, 95% CI 2.2-2.4). Prescribing rates varied widely across Census regions. CONCLUSIONS: Prescribing in hospice settings varies markedly across factors other than the clinical characteristics of enrolled patients.
引用
- Gerlach LB, Zhang L, Strominger J, et al. Hospice agency characteristics associated with benzodiazepine and antipsychotic prescribing. J Am Geriatr Soc. 2023. PMID: 36971013. doi:10.1111/jgs.18344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。